Abstract

A lipoprotein lipase (LpL) gene defect has been identified, a G----A transition at nucleotide position 446 of exon 3, resulting in a premature termination codon (Trp----stop) at amino acid residue 64. This defect was identified in a Type I hyperlipoproteinemic subject with an amino acid residue 194 defect in the other allele. Plasma lipoprotein values as well as LpL mass and activity in postheparin plasma were determined in the subjects with the residue 64 defect and in other LpL-deficient heterozygotes. LpL mass levels in both the Type I and the other subject with a 64 LpL defect were markedly reduced. This may be explained by rapid degradation of LpL protein or decreased secretion from the 64 defective allele. Alternatively, the marked reduction or absence of mass associated with the 64 defect may be due to synthesis of a severely truncated protein which escapes immunologic detection.

Highlights

  • 3, resulting in a premature termination codon (Trp + stop) at amino acid residue 64

  • Lipoprotein lipase (LpL) deficiency is characterized by hyperchylomicronemia, which is often accompanied by lipemia retinalis, pancreatitis, and eruptive xanthomas [1]

  • An LpL protein defect resulting from a premature termination codon is presented, and the defects observed in the nuclear family are characterized

Read more

Summary

Introduction

3, resulting in a premature termination codon (Trp + stop) at amino acid residue 64 This defect was identified in a Type I hyperlipoproteinemic subject with an amino acid residue 194 defect in the other allele. Plasma lipoprotein values as well as LpL mass and activity in postheparin plasma were determined in the subjects with the residue 64 defect and in other LpLdeficient heterozygotes. LpL mass levels in both the Type I and the other subject with a 64 LpL defect were markedly reduced This may be explained by rapid degradation of LpL protein or decreased secretion from the 64 defective allele. An LpL protein defect resulting from a premature termination codon is presented, and the defects observed in the nuclear family are characterized. LpL mass levels among the two subjects with the 64 defect are quantitated by immunologic assay in postheparin plasma utilizing a monoclonal antibody, and corroborated using a polyclonal assay

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call